Announced Sat, 1 Aug · 12:27 IST
Board Meeting on 13 Aug 2026 to Approve Q1 FY26 Results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹25.00
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.0+6.0+11.3+16.9+22.7+35.3+75.2+111.1——
Up moveDown movePending
AI summary
Rekvina Laboratories has informed BSE that its Board of Directors will meet on 13 August 2026 to consider and approve the unaudited standalone financial results under Ind AS for the quarter ended 30 June 2026. The trading window for designated persons is closed from 1 July 2026 until 48 hours after the results are made public.
Likely market impact
Quarterly results are upcoming. Investors should watch for Q1 FY26 earnings release on or after 13 August 2026.